In den Warenkorb
Bestellen Sie auch über:
+49 (0)241 95 163 153
+49 (0)241 95 163 155

Human CD29 Antikörper (Biotin)

Antigen

Human CD29

Klonalität Monoklonal (MEM-101A)
Wirt
Reaktivität
Alternativen

Human

Konjugat
Biotin
Applikation
Alternativen Durchflusszytometrie (FACS)
7 Publikationen vorhanden
Produktnummer ABIN234579
Menge 100ug  (Lot specific)
Preis 237,36 €   Zzgl. Versandkosten €20,00 und MWSt
Lieferung nach
Verfügbarkeit Lieferung in 5 bis 7 Werktagen

Produktbeschreibung

Immunogen Raji Burkitt?s lymphoma cell line
Format Liquid
Isotyp IgG1
Klon MEM-101A
Beschreibung MAb to CD29 Monoclonal Antibody to Human CD29 Biotin conjugated Ascites
Spezifität Reacts with CD29 (integrin beta-1 chain), a 130 kDa single chain type 1 glycoprotein expressed as a heterodimer (non-covalently associated with the integrin alpha subunits, 1-6). CD29 is broadly expressed on the majority of hematopoietic and non-hematopoietic cells (leukocytes, platelets, fibroblasts, endothelial cells, epithelial cells and mast cells). Reacts with Human, porcine and canine. Does not react with mouse.

Anwendungen

Applikationshinweise Suitable for use in Flow cytometry (1:1,000). Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
Konzentration Lot specific
Reinigung Protein A chromatography. The purified antibody is conjugated with Biotin-LC-NHS under optimum conditions. Product is free of unconjugated biotin. Source: Ascites
Buffer PBS, pH 7.4. Preservative: 15mM Sodium azide
Lagerung Short term store at 2-8°C. Long term, aliquot and store at -20°C. Avoid multiple freeze/thaw cycles.
Beschränkungen Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen Kim, Cho: "Regulatory role of ginsenoside Rp1, a novel ginsenoside derivative, on CD29-mediated cell adhesion." in: Planta medica, Vol. 75, Issue 4, pp. 316-20, 2009 (PubMed).

Handke, Oelschlegel, Franke et al.: "Hantaan virus triggers TLR3-dependent innate immune responses." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 182, Issue 5, pp. 2849-58, 2009 (PubMed).

Lomakina, Knauf, Schultz et al.: "Activation of human neutrophil Mac-1 by anion substitution." in: Blood cells, molecules & diseases, Vol. 42, Issue 3, pp. 177-84, 2009 (PubMed).

Soler, Chapman, Yang et al.: "The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases." in: The Journal of pharmacology and experimental therapeutics, Vol. 330, Issue 3, pp. 864-75, 2009 (PubMed).

Wagner, Bork, Horn et al.: "Aging and replicative senescence have related effects on human stem and progenitor cells." in: PLoS ONE, Vol. 4, Issue 6, pp. e5846, 2009 (PubMed).

Byeon, Choi, Hong et al.: "Inhibitory effect of saponin fraction from Codonopsis lanceolata on immune cell-mediated inflammatory responses." in: Archives of pharmacal research, Vol. 32, Issue 6, pp. 813-22, 2009 (PubMed).

Lee, Lee, Cho: "Cell-permeable ceramides act as novel regulators of U937 cell-cell adhesion mediated by CD29, CD98, and CD147." in: Immunobiology, 2009 (PubMed).

Alternativen

Alternativen zu Antigen "Human CD29", Typ "Antikörper" finden
Wirte Maus (1)
Reaktivitäten Human (1)
Applikationen Durchflusszytometrie (FACS) (1), Immunpräzipitation (IP) (1), Western Blot (WB) (1)